← SynDRA
CYC-065
SynDRA canonical compound SYN0038371 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | CDK2 | CDK9 |
| Mechanism of action | CDK inhibitor |
All known targets
Mechanisms of action (all sources)
- cyclin-dependent kinase inhibitor
- CDK9 INHIBITOR
- CDK2 INHIBITOR
Cross-references
Synonyms
- Fadraciclib
- Cyc065
- CYC065
- DLPIYBKBHMZCJI-WBVHZDCISA-N
- UNII-YET2XNU791
- YET2XNU791
- SCHEMBL13300946
- CHEMBL3655762
- BDBM106950
- CS-7615
- HY-101212
- US8592581, 1
- 2-Pentanol, 3-((6-(((4,6-dimethyl-3-pyridinyl)methyl)amino)-9-(1-methylethyl)-9H-purin-2-yl)amino)-, (2R,3S)-
- RefChem:139872
- Cyclin Dependent Kinase Inhibitor 2/5/9 CYC065
- Fadraciclib | CYC065
- Fadraciclib (CYC065)
- FADRACICLIB [INN]
- FADRACICLIB [WHO-DD]
- orb1296241
- SCHEMBL29362110
- SCHEMBL31702790
- C21H31N7O
- GTPL10461
- EX-A2830
- MFCD21496424
- NSC806387
- NSC-806387
- AC-31595
- BC175840
- MS-26714
- DB-145750
- G16404
- (2R,3S)-3-[[6-[(4,6-dimethylpyridin-3-yl)methylamino]-9-propan-2-ylpurin-2-yl]amino]pentan-2-ol
- RefChem:200287
- 7X248KO684
- UNII-7X248KO684
- FADRACICLIB TARTRATE
Look up CYC-065 in the interactive SynDRA portal →